Loading organizations...
Loading organizations...
Insights platform for developing medicines from human genetics.
Empirico has raised $17.0M across 1 funding round.
Empirico has raised $17.0M in total across 1 funding round.
Empirico has raised $17.0M in total across 1 funding round.
Empirico's investors include Ionis Pharmaceuticals, DCVC Bio, Neotribe Ventures.
Empirico has raised $17.0M across 1 funding round. Most recently, it raised $17.0M Series A in January 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 9, 2020 | $17.0M Series A | Ionis Pharmaceuticals | DCVC Bio, Neotribe Ventures |